Related Experiment Video

Updated: Aug 15, 2026

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
09:46

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells

Published on: December 27, 2017

Essential thrombocythemia

Guido Finazzi1, Claire Harrison

  • 1Department of Hematology, Ospedali Riuniti, Largo Barozzi 1, 24128 Bergamo, Italy. gfinazzi@ospedaliriuniti.bergamo.it

Seminars in Hematology
|October 8, 2005
PubMed

Insights

Essential thrombocythemia (ET) diagnosis needs updated criteria. Management focuses on risk stratification and preventing complications, with hydroxyurea (HU) plus aspirin for high-risk patients.

Area of Science:

  • Hematology
  • Oncology
  • Molecular Pathogenesis

Background:

  • Essential thrombocythemia (ET) and Philadelphia chromosome-negative myeloproliferative disorders (MPDs) have seen recent advances in understanding molecular pathogenesis.
  • Current ET diagnosis relies on outdated exclusion criteria, lacking integration of recent scientific discoveries.
  • ET is associated with increased thrombotic and hemorrhagic risks and potential progression to myelofibrosis or acute myeloid leukemia (AML).

Purpose of the Study:

  • To review the current understanding of ET molecular pathogenesis.
  • To highlight the limitations of existing diagnostic criteria for ET.
  • To discuss current management strategies, including risk stratification and therapeutic options for ET.

Main Methods:

  • Review of recent scientific literature on ET and MPDs.
  • Analysis of diagnostic criteria and their limitations.
  • Evaluation of current therapeutic approaches and their associated risks.

Main Results:

  • Despite progress in understanding MPDs, ET diagnosis remains based on historical exclusion criteria.
  • ET management necessitates risk stratification to guide treatment decisions.
  • Hydroxyurea (HU) plus aspirin is supported for high-risk ET patients, with anagrelide or interferon-alpha (IFN-alpha) as second-line options.

Conclusions:

  • There is a need to update ET diagnostic criteria incorporating recent molecular insights.
  • Risk-adapted management is crucial for ET patients to mitigate vascular events and transformation.
  • Therapeutic choices for ET should consider patient risk, response to treatment, and specific situations like pregnancy (IFN-alpha preference).

More Related Videos

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis08:50

Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis

Published on: January 9, 2026

Related Concept Videos

Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Pulmonary Embolism I: Introduction01:19

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...